All posts

IMAX stock is hard to love right now, John Zechner says

John Zechner
You can’t fight city hall or in this case, the hordes of viewers choosing their own couches over the local movie theatre. That spells trouble for companies like IMAX Corp (IMAX Stock Quote, Chart NYSE:IMAX), says John Zechner of J. Zechner Associates, who argues that investors should heed the warning signs of a sector-wide shift in people’s viewing habits.

Ahead of IMAX’s third quarter earnings report due later this month the company is looking to continue its solid performance, which last quarter showed a 12.5 per cent year-over-year uptick in revenues along with a consensus beat on EPS at $0.30 per share compared to the expected $0.26 per share. (All figures in US dollars.)

The stock has been trending upwards for the past few months, gaining 13 per cent since late July, as it looks to recover some of its past glory. But don’t be fooled, says Zechner, chairman and lead equity manager at J. Zechner Associates, who points to the rise in streaming services like Netflix as a harbinger of things to come.

“It’s suffering, obviously, from the migration of the business to a different mode, of people watching from home and things like that,” says Zechner to BNN Bloomberg. “It’s gone away from the premium screen providers like IMAX and we’ve even seen it in a stock like Cineplex which is down from north of $50 to just under $30. The whole group has been under some pressure valuation wise, earnings wise.”

Can’t make value argument for IMAX stock

Just as Cineplex has made its push to diversify its revenue streams beyond the box office, through its Rec Room arcade games and media services segment, for example, IMAX appears willing to move beyond its traditional offerings with a newly created program called IMAX Enhanced, which promises to bring to the living room some of the quality sound and visuals associated with the IMAX brand.

Zechner isn’t convinced. “I don’t know if I see much of a turnaround there,” he says. “It’s very specialty.”

“You can’t argue for it on a valuation basis, so it’s a harsh story to warm up to here,” he says. “I’d be inclined to take a walk on this one. I just can’t see sticking any new money into it, that’s for sure.”

Tagged with: imax
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Verano Holdings is undervalued, Haywood says

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials NEO:VRNO) is staying… [Read More]

12 hours ago

Knight Therapeutics is a buy, Stifel says

Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:GUD) is continuing to build momentum, according to Stifel Nicolaus… [Read More]

13 hours ago

Groupon wins price target raise at Roth

Roth Capital Partners has raised its price target on Groupon (Groupon Inc Stock Quote, Chart, News, Analysts, Financials NASDAQ:GRPN) to… [Read More]

13 hours ago

Trulieve Cannabis is a buy, Beacon says

Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) delivered a strong start to fiscal 2025, beating high-end… [Read More]

16 hours ago

Green Thumb Industries should be a core holding for cannabis investors, analyst says

Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News, Analysts, Financials CSE:GTII) delivered a steady first quarter and remains… [Read More]

17 hours ago

5N Plus just delivered an “exceptional” quarter, this analyst says

5N Plus (5N Plus Stock Quote, Chart, News, Analysts, Financials TSX:VNP) blew past expectations in the first quarter of 2025,… [Read More]

1 day ago